Neurosurgical imaging company Imris partnered with Siemens Healthineers, according to Star Tribune.
Here are five details:
1. Per the agreement, Imris will exclusively use and sell Siemens' MRI, computed tomography and angiography devices.
2. Although Imris will only use Siemens technology to build an Imris Surgical Theater, the company will continue to use equipment and devices from various manufacturers.
3. The Imris Surgical Theater is designed to allow neurosurgeons to conduct imaging without transferring the patient out of the operating room. The neurosurgeon can then alter the surgical pathway while the procedure is in progress.
4. The surgical theater costs between $1.5 million and $10 million. Neurosurgeons have reported a 30-point increase in the percentage of patients with tumors completely removed when intraoperative imaging is used
5. When asked the possibility of a Siemens acquisition, Imris' CEO Andrew Flanagan indicated the company is working on internal tasks to boost research and development rather than finding a buyer.